SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
90 hedge funds and large institutions have $166M invested in Syros Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 22
66% less call options, than puts
Call options by funds: $85K | Put options by funds: $249K
Holders
90
Holding in Top 10
1
Calls
$85K
Puts
$249K
Top Buyers
| 1 | +$3.26M | |
| 2 | +$1.56M | |
| 3 | +$1.49M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$554K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$538K |
Top Sellers
| 1 | -$820K | |
| 2 | -$731K | |
| 3 | -$638K | |
| 4 |
Morgan Stanley
New York
|
-$519K |
| 5 |
PP
PDT Partners
New York
|
-$429K |